http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105664171-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2016-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105664171-B |
| titleOfInvention | Immunomodulator, preparation method and application |
| abstract | The invention discloses a kind of immunomodulators, it is combined into as the compound as shown in formula (I), the CpG oligodeoxynucleotide that length is 15-30nt and the compound as shown in formula (III), and the CpG motif that the CpG oligodeoxynucleotide contains is GACGTT.The preparation method of composition, immunomodulator is also disclosed.Immunomodulator preparation is simple, can be used for the adjusting of vivo immuning system function, realizes effective treatment of immune correlated disease, for tumour treatment and effectively improve the immune effect of vaccine. |
| priorityDate | 2016-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.